The Insulin Revolution: Will Weekly Doses Bridge India's Diabetes Gap? India has become a testing ground for innovative healthcare solutions, particularly when it comes to managing its massive diabetes burden.
Over 101 million people live with the condition, while another 136 million are estimated to have prediabetes. This makes India one of the world's most pressing diabetes hotspots.
Novo Nordisk's Awiqli insulin is a new once a week basal insulin treatment that promises to simplify therapy by reducing injections from 365 per year to just 52.